IDEXX Laboratories, Inc. Stock
Equities
IDXX
US45168D1046
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
489.2 USD | -1.04% | +2.40% | -11.86% |
Apr. 01 | Elanco Animal Health Appoints Two Ancora Holdings' Nominees to Board | MT |
Apr. 01 | Elanco appoints two directors after settling with activist Ancora | RE |
Financials (USD)
Sales 2024 * | 3.99B | Sales 2025 * | 4.39B | Capitalization | 40.65B |
---|---|---|---|---|---|
Net income 2024 * | 928M | Net income 2025 * | 1.04B | EV / Sales 2024 * | 10.3 x |
Net Debt 2024 * | 461M | Net Debt 2025 * | 264M | EV / Sales 2025 * | 9.31 x |
P/E ratio 2024 * |
44
x | P/E ratio 2025 * |
38.7
x | Employees | 11,000 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 76.52% |
Latest transcript on IDEXX Laboratories, Inc.
1 day | -1.04% | ||
1 week | +2.40% | ||
Current month | -9.39% | ||
1 month | -7.64% | ||
3 months | -6.35% | ||
6 months | +18.55% | ||
Current year | -11.86% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 12-07-31 | |
Brian McKeon
DFI | Director of Finance/CFO | 61 | 03-06-30 |
John Hart
COO | Chief Operating Officer | - | 07-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Junius
BRD | Director/Board Member | 71 | 14-03-10 |
M. Szostak
BRD | Director/Board Member | 73 | 12-07-15 |
Chairman | 61 | 16-10-18 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
8.32% | 1 M€ | -.--% | ||
1.59% | 18 M€ | +3.79% | - | |
1.14% | 2 M€ | -1.17% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 489.2 | -1.02% | 358,641 |
24-04-24 | 494.3 | +0.09% | 493,145 |
24-04-23 | 493.8 | +2.97% | 558,418 |
24-04-22 | 479.6 | +0.68% | 419,598 |
24-04-19 | 476.4 | -0.30% | 568,646 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
- Stock Market
- Equities
- IDXX Stock